Human adrenal LH/hCG receptors and what they could mean for adrenal physiology and pathology

Molecular and Cellular Endocrinology

Volumn 329, Issue 1-2, 2010, Pages 33-36

  Rao, C V ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Cancer; HCG receptor; LH receptor

Indexed keywords

CHORIONIC GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6;

ADRENAL CORTEX; ADRENAL GLAND; CUSHING SYNDROME; EPIGENETICS; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SULFATION; UPREGULATION; ZONA FASCICULATA;

ADRENAL CORTEX; ADRENAL GLAND NEOPLASMS; ANIMALS; HUMANS; MICE; RECEPTORS, LH;

EID: 77957153861     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.05.012     Document Type: Review

References (47)

1. Abdallah M.A., Lei Z.M., Li X., Greenwold N., Nakajima S.T., Jauniaux E., Rao Ch.V. Human fetal nongonadal tissues contain human chorionic gonadotropin/luteinizing hormone receptors. J. Clin. Endocrinol. Metab. 2004, 89:952-956.
2. Alevizaki M., Saltiki K., Mantzou E., Anastasiou E., Huhtaniemi I. The adrenal gland may be a target of LH action in postmenopausal women. Eur. J. Endocrinol. 2006, 154:875-881.
3. Apter D., Pakarinen A., Hammond G.L., Vihko R. Adrenocortical function in puberty. Serum ACTH, cortisol and dehydroepiandrosterone in girls and boys. Acta Paediatr. Scand. 1979, 68:599-604.
4. Bernichtein S., Alevizaki M., Huhtaniemi I.T. Is the adrenal cortex a target for gonadotropins?. Trends Endocrinol. Metab. 2008, 509:231-238.
5. Bernichtein S., Petretto E., Jamieson S., Goel A., Aitman T.J., Mangion J.M., Huhtaniemi I.T. Adrenal gland tumorigenesis after gonadectomy in mice is a complex genetic trait driven by epistatic loci. Endocrinology 2008, 149:651-661.
6. Blichert-Toft M., Vejlsted H., Hehlet H., Albrechtsen R. Virilizing adrenocortical adenoma responsive to gonadotrophin. Acta Endocrinol. (Copenh.) 1975, 78:77-85.
7. Bugalho M.J., Li X., Rao C.V., Soares J., Sobrinho L.G. Presence of a Gs alpha mutation in an adrenal tumor expressing LH/hCG receptors and clinically associated with Cushing's syndrome. Gynecol. Endocrinol. 2000, 14:50-54.
8. Chang R.J., Mandel F.P., Wolfsen A.R., Judd H.L. Circulating levels of plasma adrenocorticotropin in polycystic ovary disease. J. Clin. Endocrinol. Metab. 1982, 54:1265-1267.
9. Close C.F., Mann M.C., Watts J.F., Taylor K.G. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. Clin. Endocrinol. (Oxf.) 1993, 39:375-379.
10. Connell M., Mixon R.L., Brissie R.M., Parker C.R.J. Age effects on immunohistochemical localization of DHEA sulfotransferase in the adrenal cortex of women. J. Soc. Gynecol. Invest. 1999, (Suppl.):92A-93A. (Abstract 185).
11. de Lange W.E., Pratt J.J., Doorenbos H. A gonadotrophin responsive testosterone producing adrenocortical adenoma and high gonadotrophin levels in an elderly woman. Clin. Endocrinol. (Oxf.) 1980, 12:21-28.
12. Feelders R.A., Lamberts S.W., Hofland L.J., van Koetsveld P.M., Verhoef-Post M., Themmen A.P., de Jong F.H., Bonjer H.J., Clark A.J., van der Lely A.J., de Herder W.W. Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. J. Clin. Endocrinol. Metab. 2003, 88:230-237.
13. Fotherby K. Endocrinology of Menstrual Cycle and Pregnancy (Biochemistry of Steroid Hormones) 1984, Blackwell Scientific, Oxford, pp. 409-440.
14. Goodarzi M.O., Dawson D.W., Li X., Lei Z., Shintaku P., Rao C.V., Van Herle A.J. Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone. J. Clin. Endocrinol. Metab. 2003, 88:73-77.
15. Han S.W., Lei Z.M., Rao C.V. Homologous down-regulation of luteinizing hormone/chorionic gonadotropin receptors by increasing the degradation of receptor transcripts in human uterine endometrial stromal cells. Biol. Reprod. 1997, 57:158-164.
16. Herman Chui M., Ozbey N.C., Ezzat S., Kapran Y., Erbil Y., Asa S.L. Case report: adrenal LH/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing's syndrome. Endocr. Pathol. 2009.
17. Hofmann G.E., Rao C.V., Barrows G.H., Schultz G.S., Sanfilippo J.S. Binding sites for epidermal growth factor in human uterine tissues and leiomyomas. J. Clin. Endocrinol. Metab. 1984, 58:880-884.
18. Jaffe R.B., Seron-ferre M., Huhtanieni I., Korenbrot C. Regulation of the primate fetal adrenal gland and testis in vetro and in vivo. J Steroid. Biochem. 1977, 8:479-490.
19. Hornsby P.J. Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Ann. N. Y. Acad. Sci. 1995, 774:29-46.
20. Kero J., Poutanen M., Zhang F.P., Rahman N., McNicol A.M., Nilson J.H., Keri R.A., Huhtaniemi I.T. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J. Clin. Invest. 2000, 105:633-641.
21. Lacroix A., Hamet P., Boutin J.M. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N. Engl. J. Med. 1999, 341:1577-1581.
22. Lehmann W.D., Lauritzen C. HCG+ACTH stimulation of in vitro dehydroepiandrosterone production in human fetal adrenals from precursor cholesterol and delta5-pregnenolone. J. Perinat. Med. 1975, 3:231-236.
23. Leinonen P., Ranta T., Siegberg R., Pelkonen R., Heikkila P., Kahri A. Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors and 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf.) 1991, 34:31-35.
24. Liddle G.W. The Adrenals (Textbook of Endocrinology, Volume 6th) 1981, W.B. Saunders Co., Philadelphia, pp. 249-290.
25. Liu L., Jaffe R., Borowski G.D., Rose L.I. Exacerbation of Cushing's disease during pregnancy. Am. J. Obstet. Gynecol. 1983, 145:110-111.
26. Lobo R.A., Granger L.R., Paul W.L., Goebelsmann U., Mishell D.R. Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. Am. J. Obstet. Gynecol. 1983, 145:496-503.
27. Mazzuco T.L., Chabre O., Feige J.J., Thomas M. Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. J. Clin. Endocrinol. Metab. 2006, 91:196-203.
28. Mircescu H., Jilwan J., N'Diaye N., Bourdeau I., Tremblay J., Hamet P., Lacroix A. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?. J. Clin. Endocrinol. Metab. 2000, 85:3531-3536.
29. Morris, L.F., Park, S., Daskivich, T., Churchill, B.M., Rao, C.V., Lei, Z.M., Martinez, D., Yeh, M.W. Virilization of a female infant by a maternal adrenocortical carcinoma, submitted for publication.
30. Pabon J.E., Li X., Lei Z.M., Sanfilippo J.S., Yussman M.A., Rao C.V. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J. Clin. Endocrinol. Metab. 1996, 81:2397-2400.
31. Parker C.R., Jian M., Conley A.J. The localization of DHEA sulfotransferase in steroidogenic and steroid metabolizing tissues of the adult rhesus macaque monkey. Endocr. Res. 2000, 26:517-522.
32. Parker C.R., Mixon R.L., Brissie R.M., Grizzle W.E. Aging alters zonation in the adrenal cortex of men. J. Clin. Endocrinol. Metab. 1997, 82:3898-3901.
33. Parker L.N. Adrenarche. Endocrinol. Metab. Clin. N. Am. 1991, 20:71-83.
34. Parker L.N. Control of adrenal androgen secretion. Endocrinol. Metab. Clin. N. Am. 1991, 20:401-421.
35. Parker L.N., Odell W.D. Control of adrenal androgen secretion. Endocr. Rev. 1980, 1:392-410.
36. Parviainen H., Kiiveri S., Bielinska M., Rahman N., Huhtaniemi I.T., Wilson D.B., Heikinheimo M. GATA transcription factors in adrenal development and tumors. Mol. Cell. Endocrinol. 2007, 265-266:17-22.
37. Pierce J.G., Parsons T.F. Glycoprotein hormones: structure and function. Annu. Rev. Biochem. 1981, 50:465-495.
38. Rainey W.E., Bird I.M., Mason J.I. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol. Cell. Endocrinol. 1994, 100:45-50.
39. Rainey W.E., Bird I.M., Sawetawan C., Hanley N.A., McCarthy J.L., McGee E.A., Wester R., Mason J.I. Regulation of human adrenal carcinoma cell (NCI-H295) production of C19 steroids. J. Clin. Endocrinol. Metab. 1993, 77:731-737.
40. Rao Ch.V., Zhou X.L., Lei Z.M. Functional luteinizing hormone/chorionic gonadotropin receptors in human adrenal cortical H295R cells. Biol. Reprod. 2004, 71:579-587.
41. Saner-Amigh K., Mayhew B.A., Mantero F., Schiavi F., White P.C., Rao C.V., Rainey W.E. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 2006, 91:1136-1142.
42. Seron-Ferre M., Lawrence C.C., Jaffe R.B. Role of hCG in regulation of the fetal zone of the human fetal adrenal gland. J. Clin. Endocrinol. Metab. 1978, 46:834-837.
43. Sklar C.A., Kaplan S.L., Grumbach M.M. Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J. Clin. Endocrinol. Metab. 1980, 51:548-556.
44. Takahashi H., Yoshizaki K., Kato H., Masuda T., Matsuka G., Mimura T., Inui Y., Takeuchi S., Adachi H., Matsumoto K. A gonadotrophin-responsive virilizing adrenal tumour identified as a mixed ganglioneuroma and adreno-cortical adenoma. Acta Endocrinol. (Copenh.) 1978, 89:701-709.
45. Warne G.L., Carter J.N., Faiman C., Reyes F.I., Winter J.S. The relationship of adrenal androgens to the secretory patterns for cortisol, prolactin, and growth hormone during early puberty. Pediatr. Res. 1979, 13:211-213.
46. Werk E.E., Sholiton L.E., Kalejs L. Testosterone-secreting adrenal adenoma under gonadotropin control. N. Engl. J. Med. 1973, 289:767-770.
47. Wy L.A., Carlson H.E., Kane P., Li X., Lei Z.M., Rao C.V. Pregnancy-associated Cushing's syndrome secondary to a luteinizing hormone/human chorionic gonadotropin receptor-positive adrenal carcinoma. Gynecol. Endocrinol. 2002, 16:413-417.